Regeneron Pharmaceuticals
REGN
#370
Rank
โ‚น6.640 T
Marketcap
โ‚น63,339
Share price
0.63%
Change (1 day)
31.27%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): โ‚น458.22 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น14.91 Billion. In 2025 the company made an earning of โ‚น505.03 Billion, an increase over its 2024 earnings that were of โ‚น461.50 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น458.22 B-9.27%
2025 โ‚น505.03 B9.43%
2024 โ‚น461.50 B13.83%
2023 โ‚น405.45 B-13.57%
2022 โ‚น469.12 B-47.9%
2021 โ‚น900.42 B144.75%
2020 โ‚น367.90 B56.86%
2019 โ‚น234.53 B-4.87%
2018 โ‚น246.55 B22.86%
2017 โ‚น200.68 B56.3%
2016 โ‚น128.39 B8.55%
2015 โ‚น118.28 B54.53%
2014 โ‚น76.54 B11.14%
2013 โ‚น68.87 B72.13%
2012 โ‚น40.01 B-285.93%
2011 -โ‚น21.53 Billion121.73%
2010 -โ‚น9.71 Billion37.18%
2009 -โ‚น7.08 Billion-14.6%
2008 -โ‚น8.29 Billion-25.02%
2007 -โ‚น11.06 Billion6.32%
2006 -โ‚น10.4 Billion-186.52%
2005 โ‚น12.01 B2103.7%
2004 โ‚น0.54 B-105.66%
2003 -โ‚น9.64 Billion-18.18%
2002 -โ‚น11.78 Billion42.33%
2001 -โ‚น8.28 Billion129.35%
2000 -โ‚น3.61 Billion51.87%
1999 -โ‚น2.38 Billion92.19%
1998 -โ‚น1.24 Billion66.23%
1997 -โ‚น0.75 Billion-55.49%
1996 -โ‚น1.68 Billion103.53%
1995 -โ‚น0.83 Billion-70.89%
1994 -โ‚น2.82 Billion-26.08%
1993 -โ‚น3.82 Billion114.67%
1992 -โ‚น1.78 Billion196.77%
1991 -โ‚น0.6 Billion87.88%
1990 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.508 T 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.523 T 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น877.36 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น739.44 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น156.70 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น83.96 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA